This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through November 3, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor
by Zacks Equity Research
Pulse Biosciences partners with MD Anderson to study its nPulse technology for treating benign and malignant thyroid tumors upon receiving FDA approval for a first-in-human trial.
ISRGNegative Net Change VCYTNegative Net Change PLSEPositive Net Change AORTPositive Net Change
medical medical-devices
Here's Why You Should Add Cencora Stock to Your Portfolio Now
by Zacks Equity Research
Cencora's U.S. Healthcare Solutions strength, RCA gains, and raised FY25 guidance underscore its accelerating growth momentum.
ISRGNegative Net Change CORPositive Net Change VCYTNegative Net Change MEDPPositive Net Change
medical medical-devices
Is it Worth Retaining NEOG Stock in Your Portfolio for Now?
by Zacks Equity Research
Neogen leans on new product launches and 3M Food Safety integration to offset solvency strains and macro pressures.
OMCLPositive Net Change ILMNPositive Net Change NEOGPositive Net Change BTSGNegative Net Change
medical medical-devices
Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?
by Zacks Equity Research
PAHC's 59% YTD surge rides on strong Animal Health momentum, booming vaccines and global gains despite the rising competition.
OMCLPositive Net Change ILMNPositive Net Change PAHCPositive Net Change BTSGNegative Net Change
medical medical-devices
Reasons to Retain TransMedics Stock in Your Portfolio for Now
by Zacks Equity Research
TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.
BSXPositive Net Change ISRGNegative Net Change MEDPPositive Net Change TMDXNegative Net Change
medical medical-devices
Hims & Hers Plunges 29.1% in 6 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS expands into Canada and Europe while facing regulatory hurdles and execution risks in weight-loss care.
TDOCPositive Net Change GDRXPositive Net Change HIMSNegative Net Change
medical medical-devices
Is Tempus AI Stock a Buy Now or a Hold After a Big 2025 Run?
by Urmimala Biswas
Tempus AI rallies in 2025, but a Hold rank and mixed style scores argue for patience until pricing, FDA, and MRD milestones firm up.
IQVPositive Net Change GHPositive Net Change TEMNegative Net Change
artificial-intelligence earnings-report healthcare medical medical-devices valuation
Should You Buy Alpine Income (PINE) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
PINENegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
by Zacks Equity Research
Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.
ISRGNegative Net Change MEDPPositive Net Change CARLNegative Net Change
medical medical-devices
Here's Why You Should Retain OPKO Health Stock in Your Portfolio Now
by Zacks Equity Research
OPK leans on RAYALDEE momentum and strategic partnerships as pipeline trials advance, though reliance on its lone U.S. drug adds risk.
BSXPositive Net Change ISRGNegative Net Change OPKPositive Net Change MEDPPositive Net Change
medical medical-devices
RMD Stock Set to Gain From FDA Clearance of AI-Enabled Smart Comfort
by Zacks Equity Research
Resmed gains FDA's nod for Smart Comfort, an AI-driven CPAP tool boosting sleep therapy personalization and adherence.
OMCLPositive Net Change ILMNPositive Net Change RMDPositive Net Change BTSGNegative Net Change
medical medical-devices
CONMED Stock Falls as It Strategically Exits Gastroenterology Portfolio
by Zacks Equity Research
CNMD is set to exit its gastroenterology portfolio to streamline its focus on higher-growth surgical platforms and boost long-term margins.
BSXPositive Net Change CNMDPositive Net Change ISRGNegative Net Change MEDPPositive Net Change
medical medical-devices
Tempus AI: Data Flywheel and MRD Expansion Reshape the Outlook
by Urmimala Biswas
Tempus AI's data engine, MRD buildout and ADLT milestones set the stage for faster growth while profitability metrics turn the corner.
ILMNPositive Net Change GHPositive Net Change TEMNegative Net Change
artificial-intelligence earnings-report healthcare medical medical-devices
The Pennant Group, Inc. (PNTG) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
PNTGPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?
by Moumi Mondal
Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.
ABTPositive Net Change HOLXPositive Net Change QGENPositive Net Change
medical medical-devices
ISRG Stock Forms Golden Crossover: Will the Uptrend Continue?
by Indrajit Bandyopadhyay
Intuitive Surgical's golden crossover arrives amid surging procedures and rapid dV5 adoption, raising the stakes for its bullish momentum.
MDTPositive Net Change SYKPositive Net Change ISRGNegative Net Change
medical medical-devices
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
by Zacks Equity Research
BDX teams up with ChemoGLO to expand hazardous drug testing, aiming to boost safety in healthcare environments.
BDXPositive Net Change ISRGNegative Net Change CAHPositive Net Change SOLVPositive Net Change
medical medical-devices
GEHC Forms 7-Year Care Alliance to Advance URMC Imaging & Monitoring
by Zacks Equity Research
GE HealthCare's seven-year alliance with URMC advances imaging, precision medicine and system-wide monitoring upgrades across UR Medicine.
BSXPositive Net Change ISRGNegative Net Change MEDPPositive Net Change GEHCPositive Net Change
medical medical-devices
ATN International (ATNI) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
ATNIPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Transportadora De Gas Sa Ord B (TGS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
TGSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Si-Bone (SIBN) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SIBNNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Tempus AI: Revenue Mix and 2026 Growth Outlook Explained
by Urmimala Biswas
Tempus AI's balanced genomics and data engine is scaling fast as profitability metrics improve and 2026 revenue targets approach the billion-plus mark.
EXASPositive Net Change GHPositive Net Change TEMNegative Net Change
healthcare medical medical-devices oncology-screening
COO Gains as Q4 Earnings & Sales Beat Estimates, MyDay Adoption Rises
by Zacks Equity Research
COO jumps after Q4 earnings and sales top estimates, powered by rising MyDay demand and strong MiSight momentum.
ISRGNegative Net Change COOPositive Net Change MEDPPositive Net Change SGHTPositive Net Change
earnings medical medical-devices
Here's Why You Should Add Inogen Stock to Your Portfolio Now
by Zacks Equity Research
INGN gains momentum from rising POC demand, new product launches and strong Q3 sales, even as competition and forex swings temper near-term growth.
ISRGNegative Net Change INGNPositive Net Change MEDPPositive Net Change SGHTPositive Net Change
medical medical-devices
MDT Stock Set to Benefit From the FDA Clearance of Hugo RAS System
by Zacks Equity Research
Medtronic gains from the FDA clearance of its Hugo RAS system, expanding U.S. access to robotic-assisted urologic surgery.
MDTPositive Net Change OMCLPositive Net Change ILMNPositive Net Change BTSGNegative Net Change
medical medical-devices